Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment
- Details
- Category: Pfizer

Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
- Details
- Category: Pfizer

Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
- Details
- Category: Bayer

Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
- Details
- Category: Pfizer

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
- Details
- Category: Sanofi

Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant
- Details
- Category: Pfizer

GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- New Vaxzevria data further support its use as third dose booster
- Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
- Amgen and Arrakis Therapeutics announce multi-target collaboration to identify novel RNA degrader small molecule therapeutics
- Bayer and Mammoth Biosciences to collaborate on novel gene editing technolog
- Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
- Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine
- Pfizer and BioNTech receive U.S. FDA Emergency Use Authorization of COVID-19 vaccine booster for individuals 12 years of age and older